Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)

American Journal of Cardiology

Volumn 108, Issue 2, 2011, Pages 227-232

  Tanner, Rikki M ^a   Baber, Usman ^c   Carson, April P ^a   Voeks, Jenifer ^a   Brown, Todd M ^b   Soliman, Elsayed Z ^d   Howard, Virginia J ^a   Muntner, Paul ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SELF REPORT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; WAIST CIRCUMFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BLOOD GLUCOSE; CHOLESTEROL, HDL; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; PREVALENCE; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 79959768097     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.026     Document Type: Article

References (22)

1. S. Krishnamoorthy, and G.Y. Lip Hypertension, stroke and the impact of atrial fibrillation Expert Rev Cardiovasc Ther 6 2008 1287 1289
2. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 suppl 1998 2N 9N (Pubitemid 28507114)
3. H. Inoue, T. Nozawa, T. Hirai, S. Goto, H. Origasa, K. Shimada, S. Uchiyama, T. Hirabayashi, Y. Koretsune, S. Ono, T. Hasegawa, Y. Sasagawa, Y. Kaneko, Y. Ikeda J-TRACE Investigators Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE Circ J 74 2010 650 654
4. G.A. Nichols, K. Reinier, and S.S. Chugh Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation Diabetes Care 32 2009 1851 1856
5. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort The Framingham Heart Study JAMA 271 1994 840 844
6. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, P.M. Rautaharju CHS Research Collaborative Group Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241 (Pubitemid 24239044)
7. O.E. Johansen, E. Brustad, S. Enger, and A. Tveit Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects Cardiovasc Diabetol 7 2008 1 8
8. J.A. Díaz-Peromingo, A. Albán-Salgado, F. García-Suárez, J. Sánchez-Leira, J. Saborido-Froján, and M. Iglesias-Gallego Lipoprotein(a) and lipid profile in patients with atrial fibrillation Med Sci Monit 12 suppl 2006 CR122 CR125
9. M. Annoura, M. Ogawa, K. Kumagai, B. Zhang, K. Saku, and K. Arakawa Cholesterol paradox in patients with paroxysmal atrial fibrillation Cardiology 92 1999 21 27 (Pubitemid 30055079)
10. X. Zhang, S. Zhang, Y. Li, R.C. Detrano, K. Chen, X. Li, L. Zhao, E.J. Benjamin, and Y. Wu Association of obesity and atrial fibrillation among middle-aged and elderly Chinese Int J Obes 33 2009 1318 1325
11. V.J. Howard, M. Cushman, L. Pulley, C.R. Gomez, R.C. Go, R.J. Prineas, A. Graham, C.S. Moy, and G. Howard The reasons for geographic and racial differences in stroke study: objectives and design Neuroepidemiology 25 2005 135 143 (Pubitemid 41207066)
12. E.Z. Soliman, G. Howard, R.J. Prineas, L.A. McClure, and V.J. Howard Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic and Racial Differences in Stroke study J Electrocardiol 43 2010 209 214
13. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh CKD-EPI Collaboration A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
14. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, and S.C. Smith Jr Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
15. T. Suzuki, R. Katz, N.S. Jenny, N.A. Zakai, M.M. LeWinter, J.I. Barzilay, and M. Cushman Metabolic syndrome, inflammation, and incident heart failure in the elderly: the Cardiovascular Health Study Circ Heart Fail 1 2008 242 248
16. R.J. Prineas, E.Z. Soliman, G. Howard, V.J. Howard, M. Cushman, Z.M. Zhang, and C.S. Moy The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: Ethnic and regional distribution of atrial fibrillation in the REGARDS study J Epidemiol 19 2009 177 181
17. B.M. Psaty, T.A. Manolio, L.H. Kuller, R.A. Kronmal, M. Cushman, L.P. Fried, R. White, C.D. Furberg, and P.M. Rautaharju Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461 (Pubitemid 27425856)
18. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, and P.M. Rautaharju Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241 (Pubitemid 24239044)
19. H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D.M. Roden, S. Sasaki, and Y. Aizawa Metabolic syndrome and risk of development of atrial fibrillation: the Niigata Preventive Medicine Study Circulation 117 2008 1255 1260 (Pubitemid 351365676)
20. R. Tang, L. Gao, J. Dong, X. Liu, J. Wu, D. Long, R. Yu, X. Du, and C. Ma Metabolic syndrome in patients with atrial fibrillation in the absence of structural heart disease from a tertiary hospital in China Chin Med J 122 2009 2744 2747
21. A.S. Yasar, E. Bilen, M. Bilge, G. Ipek, E. Ipek, and O. Kirbas P-wave duration and dispersion in patients with metabolic syndrome Pacing Clin Electrophysiol 32 2009 1168 1172
22. A.M. Chamberlain, S.K. Agarwal, M. Ambrose, A.R. Folsom, E.Z. Soliman, and A. Alonzo Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 159 2010 850 856